Physician profile
Michael J Bonnette
NPI 1396128021
$16,881.00
in general payments reported to CMS, 2019-2025
26 companies · $2,956 in 2025
The $2,956 reported for 2025 was more than what 90% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,924 · 2020: $4,699 · 2021: $1,412 · 2022: $1,228 · 2023: $2,255 · 2024: $407 · 2025: $2,956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,760 · Travel and Lodging: $1,858.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,760.06 |
| Travel and Lodging | $1,857.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $3,801.45 | 2019-2023 | Senza |
| Boston Scientific Corporation | $3,448.53 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Pinnacle, INC | $2,011.41 | 2020 | |
| Saluda Medical Americas, INC. | $1,837.29 | 2023-2025 | Evoke Scs, Evoke |
| Medtronic USA, INC. | $1,329.25 | 2019-2020 | |
| Abbott Laboratories | $1,286.66 | 2022-2025 | Proclaim |
| Nalu Medical, INC. | $1,173.41 | 2022-2025 | Nalu Neurostimulation System |
| Medtronic, INC. | $686.02 | 2021-2025 | Inceptiv, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Globus Medical, INC. | $372.88 | 2025 | Senza, Omnia |
| Stryker Corporation | $202.17 | 2025 | Mild Device Kit, Optablate |
| Stimwave Technologies Incorporated | $127.91 | 2019-2020 | |
| Spr Therapeutics, INC | $107.37 | 2021 | |
| Abbvie INC. | $106.53 | 2023-2024 | Botox |
| Medline Industries LP | $66.97 | 2025 | |
| Spinal Simplicity, LLC | $50.29 | 2025 | Ha Minuteman G3-R |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $42.80 | 2021 | |
| Siemens Medical Solutions USA, INC. | $31.50 | 2022-2024 | Cios Select |
| Painteq LLC | $30.01 | 2023 | Painteq |
| Averitas Pharma INC. | $27.99 | 2024 | Qutenza |
| Tonix Medicines, INC. | $23.93 | 2025 | Tonmya |
| Si-Bone, INC. | $23.24 | 2025 | |
| Zimmer Biomet Holdings, INC. | $22.76 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Merz Pharmaceuticals, LLC | $22.30 | 2024 | Xeomin |
| Bioventus LLC | $17.15 | 2023 | Durolane |
| Vertex Pharmaceuticals Incorporated | $16.41 | 2025 | |
| Avanos Medical | $14.77 | 2025 | Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bonnette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.